CD44 and neoplasm: CD44, which is recognized either as a surface marker of cancer‐initiating cells (CICs) or cancer stem cell antigen, was utilized as a key marker for identifying BCSCs, linking with tumor aggressiveness, metastasis, and recurrence.5, 11, 12